Sonnet BioTherapeutics Holdings, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Sonnet BioTherapeutics Holdings, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q3 2024.
  • Sonnet BioTherapeutics Holdings, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending September 30, 2024 was $36.5M, a 1.67% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $36.5M -$620K -1.67% Sep 30, 2024 10-K 2024-12-17
Q3 2023 $37.1M +$5.81M +18.6% Sep 30, 2023 10-K 2024-12-17
Q3 2022 $31.3M +$8.35M +36.4% Sep 30, 2022 10-K 2023-12-14
Q3 2021 $22.9M +$14.3M +164% Sep 30, 2021 10-K 2022-12-15
Q3 2020 $8.68M +$4.95M +132% Sep 30, 2020 10-K 2021-12-17
Q4 2019 $16M +$4.32M +37.1% Dec 31, 2019 10-K 2020-03-19
Q3 2019 $3.74M Sep 30, 2019 10-K 2020-12-17
Q4 2018 $11.7M +$928K +8.65% Dec 31, 2018 10-K 2020-03-19
Q4 2017 $10.7M -$247K -2.26% Dec 31, 2017 10-K 2019-04-01
Q4 2016 $11M +$1.86M +20.4% Dec 31, 2016 10-K 2018-03-30
Q4 2015 $9.11M +$2.36M +35% Dec 31, 2015 10-K 2017-03-31
Q4 2014 $6.75M +$1.15M +20.6% Dec 31, 2014 10-K 2016-03-31
Q4 2013 $5.6M +$2.24M +66.6% Dec 31, 2013 10-K 2015-04-15
Q4 2012 $3.36M +$1.06M +45.8% Dec 31, 2012 10-K 2014-03-31
Q4 2011 $2.31M Dec 31, 2011 10-K 2013-04-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.